352 related articles for article (PubMed ID: 25880635)
1. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
[TBL] [Abstract][Full Text] [Related]
2. Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration.
Horsley PJ; Aherne NJ; Edwards GV; Benjamin LC; Wilcox SW; McLachlan CS; Assareh H; Welshman R; McKay MJ; Shakespeare TP
Asia Pac J Clin Oncol; 2015 Mar; 11(1):15-21. PubMed ID: 25227727
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multiparametric MRI-based and transrectal ultrasound-based preplans with intraoperative ultrasound-based planning for low dose rate interstitial prostate seed implantation.
Fredman ET; Traughber BJ; Gross A; Podder T; Colussi V; Vinkler R; Machtay M; Ellis RJ
J Appl Clin Med Phys; 2019 Jun; 20(6):31-38. PubMed ID: 31004396
[TBL] [Abstract][Full Text] [Related]
6. Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
Pullini S; Signor MA; Pancot M; Zuiani C; Bazzocchi M; Fongione S; Girometti R
Eur J Radiol; 2016 Apr; 85(4):764-70. PubMed ID: 26971421
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.
Zattoni F; Kawashima A; Morlacco A; Davis BJ; Nehra AK; Mynderse LA; Froemming AT; Jeffrey Karnes R
Pract Radiat Oncol; 2017; 7(1):42-49. PubMed ID: 27527896
[TBL] [Abstract][Full Text] [Related]
8. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
[TBL] [Abstract][Full Text] [Related]
9. Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy.
Couñago F; Del Cerro E; Díaz-Gavela AA; Marcos FJ; Recio M; Sanz-Rosa D; Thuissard I; Olaciregui K; Mateo M; Cerezo L
Springerplus; 2015; 4():789. PubMed ID: 26702378
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
Yoo S; Kim JK; Jeong IG
Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.
Girometti R; Pancot M; Signor MA; Urbani M; Balestreri L; Zuiani C
Radiol Med; 2018 Oct; 123(10):778-787. PubMed ID: 29752647
[TBL] [Abstract][Full Text] [Related]
12. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
13. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
14. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
[TBL] [Abstract][Full Text] [Related]
15. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience.
Tenhunen M; Korhonen J; Kapanen M; Seppälä T; Koivula L; Collan J; Saarilahti K; Visapää H
Acta Oncol; 2018 Jul; 57(7):902-907. PubMed ID: 29488426
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer.
Nguyen PL; Whittington R; Koo S; Schultz D; Cote KB; Loffredo M; Tempany CM; Titelbaum DS; Schnall MD; Renshaw AA; Tomaszewski JE; D'Amico AV
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):400-5. PubMed ID: 15145155
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of prostate cancer in radiation oncology: what radiologists need to know.
Boonsirikamchai P; Choi S; Frank SJ; Ma J; Elsayes KM; Kaur H; Choi H
Radiographics; 2013 May; 33(3):741-61. PubMed ID: 23674772
[TBL] [Abstract][Full Text] [Related]
18. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
19. Can multiparametric MRI replace Roach equations in staging prostate cancer before external beam radiation therapy?
Girometti R; Signor MA; Pancot M; Cereser L; Zuiani C
Eur J Radiol; 2016 Dec; 85(12):2231-2237. PubMed ID: 27842672
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition.
Sachpazidis I; Mavroidis P; Zamboglou C; Klein CM; Grosu AL; Baltas D
Radiat Oncol; 2020 Oct; 15(1):242. PubMed ID: 33081804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
